A number of studies have reported NAP1L1 is upregulated and has a carcinogenic function in various tumors such as breast cancer [50], pancreatic neuroendocrine neoplasm [51], colon cancer [52] and so on. This evidence concerns the gene NAP1L1 and pancreatic neuroendocrine neoplasm.